On June 30, 2022, Mr. Shou Ziqi, Vice Chairman of Shanghai Municipal Committee of the Chinese People's Political Consultative Conference (CPPCC), visited Shanghai Vitalgen BioPharma Co., Ltd. (hereinafter referred to as “Vitalgen”) as part of his major inspection tours to “prevent the epidemic, stabilize economy and ensure security”. The accompanying government officials included Mr. Zhou Weizhong, Director of the Study and History Commission of the Shanghai Municipal CPPCC Committee.
Dr. Zhao Xiaoping, the founder and CEO of Vitalgen, received the delegation along with his senior managers, and had an in-depth exchange of views on the company's development, resumption of production and strategic planning for the future. After deeply understanding the current production and operation of the company, as well as carefully listening and responding to the focus of attention and demands from the company, Chairman Shou put forward valuable suggestions on Vitalgen's future development, while encouraging it to get engaged and involved in Shanghai's ecological conservation through scientific and technological innovation, thus contributing more in giving full play to the city's advantages and utilizing various research resources.
Vitalgen will continue to dig deeper into the transformation of the cutting-edge gene and cell therapy into clinical treatments for the benefit of more patients. We will also actively promote collaborative innovation among medical personnel, research groups and enterprises to make breakthroughs in core technologies, thereby making contributions to the high-quality development of Shanghai's biomedical industry and the building of a center for scientific and technological innovation that has global reach.